This year, Nantes and the haematology team of the CHU will welcome us. This 19st edition of the congress of the SFGM-TC will be part of the current dynamism of development in the general sense of immunotherapy, and more specifically of cell therapy.
We will talk about CAR-T cells and their current development. We will also discuss some aspects that in the current development influence our practices in cell therapy: artificial intelligence, economic aspects including the costs involved, the adaptation of hospital infrastructures to our needs and finally, certain psycho-social aspects through the philosophical notion of giving. We will also discuss the influence of microbiota, whose most recent publications show a wide influence in the context of cell therapy. Finally, during the Agencies Session, we will seek an intervention of the French High Authority of Health to better inform us about the current regulations on the actual benefit and the improvement of the actual benefit. Of course, our convention will keep poster sessions and oral presentations.
We hope that many of you will join this new edition of the congress of the SFGM-TC. It is from our dynamism that the best of ourselves will emerge. Come and join us with enthusiasm